Representative cases of the independent internal patient testing cohort for patients with an IDH-mutated glioma and an IDH-wildtype glioma that were correctly classified by all algorithms are shown in Figure 2 and Figure 3, respectively. This evidence concerns the gene IDH1 and central nervous system cancer.